Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Biobizkaia (39)

2024

  1. De-imFAR phase II project: a study protocol for a cluster randomised implementation trial to evaluate the effectiveness of de-implementation strategies to reduce low-value statin prescribing in the primary prevention of cardiovascular disease

    BMJ Open, Vol. 14, Núm. 4

  2. Prevalence of potentially inappropriate medications and prescription dynamics in elderly hospitalized patients in Spain

    BMC Geriatrics, Vol. 24, Núm. 1

  3. Use of rasburicase to improve kidney function in children with hyperuricemia and acute kidney injury

    Clinical and Experimental Nephrology, Vol. 28, Núm. 1, pp. 13-22

  4. [Translated article] Pharmaceuticals in the environment: A hospital pharmacy perspective

    Farmacia Hospitalaria, Vol. 48, pp. TS13-TS20

2023

  1. Analysis of heat stroke and heat exhaustion cases in EudraVigilance pharmacovigilance database

    European Journal of Clinical Pharmacology, Vol. 79, Núm. 5, pp. 679-685

  2. Hypersensitivity reactions associated with iron isomaltoside and ferric carboxymaltose

    European Journal of Internal Medicine

  3. Multilocus Genetic Profile Reflecting Low Dopaminergic Signaling Is Directly Associated with Obesity and Cardiometabolic Disorders Due to Antipsychotic Treatment

    Pharmaceutics, Vol. 15, Núm. 8

  4. microRNA sequencing for biomarker detection in the diagnosis, classification and prognosis of Diffuse Large B Cell Lymphoma

    Scientific reports, Vol. 13, Núm. 1, pp. 12159

2022

  1. Analysis of standard concentrations of continuous infusions in nine Spanish neonatal intensive care units

    European Journal of Hospital Pharmacy, Vol. 29, Núm. 1, pp. 50-54

  2. Applying the behavior change wheel to design de-implementation strategies to reduce low-value statin prescription in primary prevention of cardiovascular disease in primary care

    Frontiers in Medicine, Vol. 9

  3. Attachment anxiety as mediator of the relationship between childhood trauma and personality dysfunction in borderline personality disorder

    Clinical Psychology and Psychotherapy, Vol. 29, Núm. 2, pp. 501-511

  4. Drugs used during the COVID-19 first wave in Vitoria-Gasteiz (Spain) and their presence in the environment

    Science of the Total Environment, Vol. 820

  5. Podocalyxin Expressed in Antigen Presenting Cells Promotes Interaction With T Cells and Alters Centrosome Translocation to the Contact Site

    Frontiers in Immunology, Vol. 13

  6. Subacute thyroiditis and COVID-19 vaccines: a case/non-case study

    Endocrine, Vol. 77, Núm. 3, pp. 480-485

  7. Synergism interaction between genetic polymorphisms in drug metabolizing enzymes and NSAIDs on upper gastrointestinal haemorrhage: a multicenter case-control study

    Annals of medicine, Vol. 54, Núm. 1, pp. 379-392

2021

  1. A multicenter case–control study of the effect of e-nos VNTR polymorphism on upper gastrointestinal hemorrhage in NSAID users

    Scientific Reports, Vol. 11, Núm. 1

  2. Do cariprazine and brexpiprazole cause impulse control symptoms? A case/non-case study

    European Neuropsychopharmacology, Vol. 50, pp. 107-111

  3. Drug compatibility in neonatal intensive care units: gaps in knowledge and discordances

    European Journal of Pediatrics, Vol. 180, Núm. 7, pp. 2305-2313

  4. Factors influencing the effect of aripiprazole on prolactin levels in patients treated with risperidone or paliperidone. Sex seems to matter

    Schizophrenia Research, Vol. 228, pp. 382-384

  5. Intravenous drug use in neonatal intensive care units

    European Journal of Hospital Pharmacy, Vol. 28, Núm. 6, pp. 341-345